Citation: van Dijk SHB, Brusse-Keizer MGJ, Rodenburg B, Lenferink A (2025) Patterns of symptom deterioration can support multimorbidity management in COPD: Perspectives of patients and healthcare professionals. PLoS One 20(12): e0338888. https://doi.org/10.1371/journal.pone.0338888 Editor: Bijit Biswas, All India Institute of Medical Sciences, INDIA Received: June 11, 2025; Accepted: November 27, 2025; Published: December 17, 2025 Copyright: © 2025 van Dijk et al.
Anke Lenferink
Netherlands
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anke Lenferink
Consensus-based development and practice testing of a generic quality indicator set for parenteral medication administration at home: a RAND appropriateness method study
Discussion We developed a generic set with 32 QIs for PMAaH using a slightly modified RAM. The practice testing showed that it is possible to monitor the quality of both procedural and structural aspects of PMAaH pathways and that there is a need for such a set, since many QIs agreed on by directly involved experts are not yet implemented in large teaching hospitals in the Netherlands. Our research shows that many QIs are only implemented on a care pathway level, leading to variations.
Predictors of acute exacerbations in COPD: a systematic review
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 21 Authors Chamaon D , Lenferink A , Bucsán C, Van Dijk SHB , Van Beurden WJ , van der Valk PDLPM, van der Palen J , Brusse-Keizer MGJ Received 16 May 2025 Accepted for publication 10 November 2025 Published 14 February 2026 Volume 2026:21 Pages 1—26 DOI https://doi.org/10.2147/COPD.S540753 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved...
Personalizing Self-Management Interventions in COPD – Looking Be | COPD
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20 Authors Lenferink A , Brusse-Keizer MG , van der Palen J , Effing TW Received 19 December 2024 Accepted for publication 29 December 2024 Published 8 January 2025 Volume 2025:20 Pages 65—68 DOI https://doi.org/10.2147/COPD.S511278 Checked for plagiarism Yes Editor who approved publication: Dr Richard Russell Anke Lenferink,1,2 Marjolein GJ Brusse-Keizer,1,3 Job van der Palen,3,4 Tanja W Effing5,6...
Potential for personalised and biomarker-guided COPD self-treatment approaches
In this Correspondence, we use the paper of Sanjay Ramakrishnan and colleagues 1 Ramakrishnan S Jeffers H Langford-Wiley B et al. Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.
Artificial intelligence in systematic reviews: promising when appropriately used
How to maintain reliability and transparency when using AI in title and abstract screening A summary of the potential scenarios, and their pitfalls and remedies, when using the AI tool in a systematic review is given in table 1. These potential scenarios should not be ignored, but acted on to maintain reliability and transparency.
It is time to further expand research in tailoring self-management of COPD exacerbations!
Anke Lenferink, Job van der Palen, Paul D.L.P.M. van der Valk, Morton G. Burt, Peter A. Frith, Marjolein G.J. Brusse-Keizer, Tanja W. Effing European Respiratory Journal 2020 55: 1902225; DOI: 10.1183/13993003.02225-2019 Abstract Tailoring self-treatment by adding exacerbation phenotyping could be explored. Evidence on phenotyping effects, an accurate tool to identify eosinophilic exacerbations, and a validated cut-off point are needed before eosinophils can be used in practice.
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Anke Lenferink, Job van der Palen, Paul D.L.P.M. van der Valk, Paul Cafarella, Anneke van Veen, Stephen Quinn, Catharina G.M. Groothuis-Oudshoorn, Morton G. Burt, Mary Young, Peter A. Frith, Tanja W.
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Anke Lenferink, Job van der Palen, Paul D.L.P.M. van der Valk, Paul Cafarella, Anneke van Veen, Stephen Quinn, Catharina G.M. Groothuis-Oudshoorn, Morton G. Burt, Mary Young, Peter A. Frith, Tanja W.
Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
AbstractCOPD frequently exists with comorbidities, but inclusion of COPD patients with severe comorbidities in self-management trials is still relatively uncommon.In a randomised controlled self-management trial COPD patients with ? 1 comorbidity were included.
LATE-BREAKING ABSTRACT: Self-management interventions that include COPD exacerbation action plans improve health-related quality of life - A Cochrane review | European Respiratory Society
AbstractCOPD self-management interventions usually have an action plan as a key component. Studies of these interventions show contradictory results. We have assessed the effectiveness of COPD self-management interventions that include COPD exacerbation action plans compared to usual care.After a literature search, full-text articles were each independently assessed by two authors.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anke
Contact Anke, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack